“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)-Reference-Cited by-同舟云学术

“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)

Published:2012-10-24 Issue:4 Volume:7 Page:267-275
ISSN:1558-8211
Container-title:Current Hematologic Malignancy Reports
language:en
Short-container-title:Curr Hematol Malig Rep

Author:

Fields Paul A.,Taylor Graham P.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11899-012-0139-9.pdf

Reference49 articles.

1. Mier JW, Gallo RC. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA. 1980;77(10):6134–8.

2. Poiesz BJ, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415–9.

3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79(6):2031–5.

4. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Human immunodeficiency viruses and human T cell lymphotropic viruses. Lyon: IARC; 1996.

5. Murphy EL, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43(2):250–3.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Therapy for HTLV-1 Induced Adult T-Cell Leukemia/Lymphoma (ATLL): A Comprehensive Review;Pathology - Research and Practice;2024-01

2. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review;Medical Oncology;2023-09-09

3. Les Rétrovirus humains : HTLV-1, HTLV-2, HIV-1 et HIV-2;Virus émergents et Ré-émergents;2023

4. HTLV, a multi organ oncovirus;Microbial Pathogenesis;2022-08

5. TAX and HBZ: hFcγ1 proteins as targets for passive immunotherapy;IRAN J BASIC MED SCI;2022